12th March 2009
Collaboration, not competition, will define future of diagnostics
industry
- Experts envision closer strategic synergy between clinical laboratories and near patient testing
The diagnostics industry will increasingly be shaped by the relationship between the growing near patient testing (NPT) sector and a clinical laboratory system adapting to 21st Century demands, concluded an expert panel of industry, research and academic leaders at Cambridge Consultants’ fourth annual diagnostics workshop.
A new report, entitled ‘the future of diagnostics: are labs vital?’ and based on the findings of the expert panel, highlights a shift in focus by strategic planners of healthcare delivery - moving the industry away from treatment and towards prevention. In this new climate, NPT may well find a role in wellness monitoring, with self-tests removing some of the burden from clinical laboratories and Point of Care Testing. At the same time, tests in the clinical laboratory will direct clinicians to prescribe the best treatment, whilst subsequent condition monitoring with NPTs may be used to confirm the progress of the recovering patient. The panel was clear that the two services cater for largely different needs, and that as they evolve, their relationship will follow a collaborative model, rather than a directly competitive one. Over time, further niches for NPT will be identified, unblocking bottlenecks in traditional practice and lightening the load for clinical laboratories further.
"The anticipated boom in NPT has been hindered by a number of real-world barriers ranging from design issues to national health policies,” said Dr. Simon Burnell, head of diagnostics at Cambridge Consultants. “Despite these issues, near patient testing is a key trend in the industry. The challenge for the diagnostics industry will be to find the balancing point between tests that can be done effectively and confidently in the home and those that will continue to require less commercially viable processes.”
The report also points to the changes laboratories are undergoing, as scientific tools and techniques continue to advance and the drive for greater throughput and efficiency continues unabated. These changes, the panel suggested, could lead to the establishment of ultra-high throughput, massively automated ‘super-laboratories’ designed to handle well established routine tests, leaving newer and more complex tests to continue to be handled by highly skilled specialists.
“As laboratories grow to incorporate more and more features, so there will need to be increasing strategic synergy between the laboratories and NPT in order to meet the high standards expected of 21st century healthcare,” continued Dr. Burnell. “In a complex marketplace such as the diagnostics industry, these are significant challenges to be met. However, if both sides of the equation continue to play to their own respective strengths, then there can be huge benefits for the industry.”
The report highlights some other issues and challenges facing the diagnostics industry as NPT and clinical laboratories continue to evolve:
- Geographical differences in uptake of NPT technology. For example, the growth of NPT is much higher in Poland and other ‘New Europe’ states than in countries with a well established and mature laboratory system such as France, Germany and the UK
- Some regional differences will always exist in healthcare provision stemming from variations in access to technology and diversity in politics and market forces
- NPT offers developing countries the potential to leapfrog and make a rapid transition to 21st Century healthcare
- The most promising niches for NPT products are where there are clear benefits: saving consumer time; saving health systems money; maintaining or improving clinical outcomes
- NPT must establish itself as an economical, practical and proven alternative
- Improved connectivity and data management systems will allow both the clinical laboratory and NPT products to feed data seamlessly into the increasingly crucial electronic patient record
A report on the key findings from this workshop - ‘the future of diagnostics: are labs vital?’ - is available from Cambridge Consultants. For your free copy, please provide contact details at http://www.cambridgeconsultants.com/fm_diagnostics_08.html
To download a high resolution image please click on the image below:
Notes for editors:
Cambridge Consultants develops breakthrough products, creates and licenses intellectual property, and provides business consultancy in technology critical issues for clients worldwide. For over 50 years, the company has been helping its clients turn business opportunities into commercial successes, whether they are launching first-to-market products, entering new markets or expanding existing markets through the introduction of new technologies. With a team of over 300 engineers, designers, scientists and consultants, in offices in Cambridge (UK) and Boston (USA), Cambridge Consultants offers solutions across a diverse range of industries including medical technology, industrial and consumer products, transport, energy, cleantech and wireless communications.
Created by three Cambridge graduates in 1960, the company has grown into a leading technology business, renowned worldwide for its ability to solve technical problems and provide innovative, practical solutions to commercial issues. In 2009, the company was awarded the prestigious Queen’s Award for Enterprise in International Trade, and in 2011 was awarded a second Queen's Award, this time for Innovation. For more information visit: www.CambridgeConsultants.com
Cambridge Consultants is part of Altran, the European leader in innovation and high technology consulting. The Group’s 17,500 consultants, operating worldwide, cover the entire range of engineering specialities, including electronics, information technology, quality and organisation. Altran offers its clients ongoing support throughout the innovation cycle, from technology watch, applied basic research and management consulting to industrial systems engineering and information systems. The Group provides services to most industries, including the automotive, aeronautics, space, life sciences and telecommunications sectors. Founded in 1982, Altran operates in 20 priority countries. In 2010, it generated a turnover of €1,430 million. For more information visit: www.altran.com
For further information:
Cambridge Consultants
Patrick Pordage
Marketing Communications Director
Tel: +44 1223 420024
Patrick.Pordage@CambridgeConsultants.com
European PR
Ben Smith
EML
Tel: +44 20 8408 8000
cambridgeconsultants@eml.com
USA PR
Travis Small
Rasky Baerlein
Tel: +1 617 443 9933 etx:356
cambridgeconsultants@eml.com





